176 related articles for article (PubMed ID: 31186956)
21. Surgical treatment of small bowel cancer: a 20-year single institution experience.
Ito H; Perez A; Brooks DC; Osteen RT; Zinner MJ; Moore FD; Ashley SW; Whang EE
J Gastrointest Surg; 2003 Nov; 7(7):925-30. PubMed ID: 14592670
[TBL] [Abstract][Full Text] [Related]
22. Prognostic factors in primary adenocarcinoma of the small intestine: 13-year single institution experience.
Chaiyasate K; Jain AK; Cheung LY; Jacobs MJ; Mittal VK
World J Surg Oncol; 2008 Jan; 6():12. PubMed ID: 18237404
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the prognosis for N2 status in patients with small bowel neuroendocrine tumors.
Wonn SM; Ratzlaff AN; Pommier SJ; Limbach KE; Bassale S; McCully BH; Pommier RF
Am J Surg; 2021 Jun; 221(6):1135-1140. PubMed ID: 33785207
[TBL] [Abstract][Full Text] [Related]
24. Mesenteric Tumor Deposits in Midgut Small Intestinal Neuroendocrine Tumors Are a Stronger Indicator Than Lymph Node Metastasis for Liver Metastasis and Poor Prognosis.
Fata CR; Gonzalez RS; Liu E; Cates JM; Shi C
Am J Surg Pathol; 2017 Jan; 41(1):128-133. PubMed ID: 27684993
[TBL] [Abstract][Full Text] [Related]
25. Adenocarcinoma of the small bowel at a single Korean institute: management and prognosticators.
Moon YW; Rha SY; Shin SJ; Chang H; Shim HS; Roh JK
J Cancer Res Clin Oncol; 2010 Mar; 136(3):387-94. PubMed ID: 19760196
[TBL] [Abstract][Full Text] [Related]
26. Neuroendocrine tumors in the Iran Cancer Institute: predictive factors of patient survival.
Sadighi S; Roshanaee G; Vahedi S; Jahanzad E; Mohagheghi MA; Mousavi-Jarahi A
Asian Pac J Cancer Prev; 2014; 15(18):7835-8. PubMed ID: 25292073
[TBL] [Abstract][Full Text] [Related]
27. Impact of tumor site on the prognosis of small bowel adenocarcinoma.
Falcone R; Romiti A; Filetti M; Roberto M; Righini R; Botticelli A; Pilozzi E; Ghidini M; Pizzo C; Mazzuca F; Marchetti P
Tumori; 2019 Dec; 105(6):524-528. PubMed ID: 30935289
[TBL] [Abstract][Full Text] [Related]
28. Prognostic clinicopathological factors after curative resection of small bowel adenocarcinoma.
Inoue Y; Hayashi M; Satou N; Miyamoto Y; Hirokawa F; Asakuma M; Shimizu T; Kayano H; Yamamoto M; Yamana H; Okuda J; Egashira Y; Tanigawa N
J Gastrointest Cancer; 2012 Jun; 43(2):272-8. PubMed ID: 21607548
[TBL] [Abstract][Full Text] [Related]
29. Is there a role for adjuvant therapy in resected adenocarcinoma of the small intestine.
Overman MJ; Kopetz S; Lin E; Abbruzzese JL; Wolff RA
Acta Oncol; 2010 May; 49(4):474-9. PubMed ID: 20397775
[TBL] [Abstract][Full Text] [Related]
30. The incidence, treatment and survival of patients with rare types of rectal malignancies in the Netherlands: A population-based study between 1989 and 2018.
van Rees JM; Elferink MAG; Tanis PJ; de Wilt JHW; Burger JWA; Verhoef C
Eur J Cancer; 2021 Jul; 152():183-192. PubMed ID: 34118528
[TBL] [Abstract][Full Text] [Related]
31. Revisiting a dogma: similar survival of patients with small bowel and gastric GIST. A population-based propensity score SEER analysis.
Guller U; Tarantino I; Cerny T; Ulrich A; Schmied BM; Warschkow R
Gastric Cancer; 2017 Jan; 20(1):49-60. PubMed ID: 26649434
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of surgery and chemotherapy for stage IV small bowel adenocarcinoma: A population-based analysis using Surveillance, Epidemiology, and End Result Program database.
Liu T; Wu Y; Jiang T
Cancer Med; 2020 Sep; 9(18):6638-6645. PubMed ID: 32750232
[TBL] [Abstract][Full Text] [Related]
33. Prognostic factors and treatment outcomes in patients with non-ampullary small bowel adenocarcinoma: Long-term analysis.
Tian J; Liu J; Guo C; Yang X; Yang Y; Gou H; Qiu M; Cao D
Medicine (Baltimore); 2019 Apr; 98(17):e15381. PubMed ID: 31027129
[TBL] [Abstract][Full Text] [Related]
34. Small bowel malignancies: a review of 29 patients at a single centre.
Kam MH; Barben CP; Eu KW; Seow-Choen F
Colorectal Dis; 2004 May; 6(3):195-7. PubMed ID: 15109386
[TBL] [Abstract][Full Text] [Related]
35. Comparison of Demographics, Tumor Characteristics, and Survival Between Pancreatic Adenocarcinomas and Pancreatic Neuroendocrine Tumors: A Population-based Study.
Yadav S; Sharma P; Zakalik D
Am J Clin Oncol; 2018 May; 41(5):485-491. PubMed ID: 27322698
[TBL] [Abstract][Full Text] [Related]
36. Value of Tumor Growth Rate (TGR) as an Early Biomarker Predictor of Patients' Outcome in Neuroendocrine Tumors (NET)-The GREPONET Study.
Lamarca A; Crona J; Ronot M; Opalinska M; Lopez Lopez C; Pezzutti D; Najran P; Carvhalo L; Franca Bezerra RO; Borg P; Vietti Violi N; Vidal Trueba H; de Mestier L; Schaefer N; Sundin A; Costa F; Pavel M; Dromain C;
Oncologist; 2019 Nov; 24(11):e1082-e1090. PubMed ID: 30910869
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathologic characteristics and prognosis of gastroenteropancreatic neuroendocrine neoplasms: a multicenter study in South China.
Fang C; Wang W; Zhang Y; Feng X; Sun J; Zeng Y; Chen Y; Li Y; Chen M; Zhou Z; Chen J
Chin J Cancer; 2017 Jun; 36(1):51. PubMed ID: 28637502
[TBL] [Abstract][Full Text] [Related]
38. Localized high-grade gastroenteropancreatic neuroendocrine tumors: Defining prognostic and therapeutic factors for a disease of increasing clinical significance.
Mosquera C; Koutlas NJ; Fitzgerald TL
Eur J Surg Oncol; 2016 Oct; 42(10):1471-7. PubMed ID: 27528467
[TBL] [Abstract][Full Text] [Related]
39. New aspects of prognostic factors in adenocarcinomas of the small bowel.
Brücher BL; Stein HJ; Roder JD; Busch R; Fink U; Werner M; Siewert JR
Hepatogastroenterology; 2001; 48(39):727-32. PubMed ID: 11462914
[TBL] [Abstract][Full Text] [Related]
40. Primary small bowel malignancies: single-center results of three decades.
Ojha A; Zacherl J; Scheuba C; Jakesz R; Wenzl E
J Clin Gastroenterol; 2000 Apr; 30(3):289-93. PubMed ID: 10777190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
